发明名称 COMBINATION OF GERANYLGERANYLACETONE AND IBUDILAST AND METHODS OF USING SAME
摘要 The present invention relates generally to methods for treating progressive neurodegenerative diseases, including their progressive forms. In particular, the present invention pertains to methods of treating or preventing progressive neurodegenerative diseases and its associated symptoms by administration of a combination of geranylgeranylacetone (teprenone) and ibudilast (3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine), or pharmaceutically acceptable salts thereof.
申请公布号 US2015366847(A1) 申请公布日期 2015.12.24
申请号 US201514742274 申请日期 2015.06.17
申请人 MediciNova, Inc. 发明人 MATSUDA Kazuko;IWAKI Yuichi
分类号 A61K31/437;A61K31/121 主分类号 A61K31/437
代理机构 代理人
主权项 1. A method of alleviating negative effects of a neurodegenerative disease or disorder in a human patient suffering therefrom, comprising administering to a patient in need thereof: (a) a therapeutically effective amount of ibudilast or a pharmaceutically acceptable salt thereof, and (b) a therapeutically effective amount of geranylgeranylacetone (GGA) or a pharmaceutically acceptable salt thereof.
地址 La Jolla CA US